1-8 of 8
Christer Paul
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marks

Stefan Deneberg, Philippe Guardiola, Andreas Lennartsson, Ying Qu, Verena Gaidzik, Odile Blanchet, Mohsen Karimi, Sofia Bengtzén, Hareth Nahi, Bertil Uggla, Ulf Tidefelt, Martin Höglund, Christer Paul, Karl Ekwall, Konstanze Döhner, Sören Lehmann
Journal: Blood
Blood (2011) 118 (20): 5573–5582.
https://doi.org/10.1182/blood-2011-01-332353
Published: 2011
Includes: Supplemental data
Journal Articles

Implications On Drug Resistance and Survival of ABCB1 Single Nucleotide Polymorphisms in Normal Karyotype De Novo AML.

Christer Paul, Henrik Green, PhD, Ingrid Jakobsen Falk, B.Sc., Kourosh Lotfi, MD, PhD, Esbjorn Paul, MD, Monika Hermansson, PhD, Richard Rosenquist, Kerstin Jonsson-Videsater, PhD, Hareth Nahi, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2648.
https://doi.org/10.1182/blood.V114.22.2648.2648
Published: 2009
Journal Articles

In Vitro and Ex Vivo Studies On Cell Lines and Primary Human Leukemia Cells of the Effects of APR-246 Alone and in Combination with Conventional Chemotherapeutic Drugs.

Kerstin Jonsson-Videsater, Dina Ali, MD, Hareth Nahi, Sofia Bengtzen, Stefan Deneberg, Christer Paul, Professor, Soren Lehmann, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2751.
https://doi.org/10.1182/blood.V114.22.2751.2751
Published: 2009
Journal Articles

Time and Dose Dependent Synergism Between Conventional Cytostatics and the p53-Modulating Small Molecule PRIMA-Meth in p53 Mutated Leukemic Cells

Dina Ali, MD, Christer Paul, S.ören Lehmann, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 5029.
https://doi.org/10.1182/blood.V112.11.5029.5029
Published: 2008
Journal Articles

Low Expression of p14 ARF in De Novo AML with Normal Karyotype Is Associated with Short Survival but Increased in Vitro Sensitivity to p53 Modulating Drugs

Esbjörn Paul, Bertil Uggla, Kals G Wiman, Christer Paul, Soren Lehmann, MD, PhD, Hareth Nahi
Journal: Blood
Blood (2008) 112 (11): 2937.
https://doi.org/10.1182/blood.V112.11.2937.2937
Published: 2008
Journal Articles

Different Incidence and Implications of DNA Hypermethylation in De Novo AML Compared to High-Risk MDS and AML Following MDS.

Stefan Deneberg, Michael Grövdal, Monika Jansson, Verena I. Gaidzik, Andrea Corbacioglu, Hareth Nahi, MD, PhD, Sofia Bengtzen, Konstanze Döhner, Christer Paul, Eva Hellström-Lindberg, Sören Lehmann, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 3337.
https://doi.org/10.1182/blood.V112.11.3337.3337
Published: 2008
Journal Articles

RITA Activates p53 Function in Chronic Lymphocytic Leukaemia Cells and Induces Apoptosis.

Hareth Nahi, MD, Mats Merup, MD/PhD, Lars Möllgård, MD/PhD, Galina Selivanova, Christer Paul
Journal: Blood
Blood (2005) 106 (11): 5536.
https://doi.org/10.1182/blood.V106.11.5536.5536
Published: 2005
Journal Articles

Effects of the FLT3 Inhibitor PKC 412 in Combination with Cytostatic Drugs In Vitro in Acute Myeloid Leukemia.

Lars Möllgård, MD PhD, Sofia Bengtzen, Thoas Fioretos, Anna Andersson, Christer Paul, Sören Lehmann, MD PhD
Journal: Blood
Blood (2004) 104 (11): 1810.
https://doi.org/10.1182/blood.V104.11.1810.1810
Published: 2004